Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma

SA Abdel-Rahman, M Gabr - Cancers, 2024 - mdpi.com
Simple Summary Glioblastoma (GBM) is an aggressive brain tumor with limited treatment
success. Despite efforts, the prognosis remains poor, impacting patients' quality of life …

Perspectives on current approaches to virtual screening in drug discovery

I Muegge, J Bentzien, Y Ge - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction For the past two decades, virtual screening (VS) has been an efficient hit finding
approach for drug discovery. Today, billions of commercially accessible compounds are …

Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors

SA Abdel-Rahman, V Ovchinnikov… - ACS Medicinal …, 2024 - ACS Publications
Blocking the immunosuppressive function of T-cell immunoglobulin mucin-3 (TIM-3) is an
established therapeutic strategy to maximize the efficacy of immune checkpoint inhibitors for …

Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction

SA Abdel‐Rahman, BL Santini, L Calvo-Barreiro… - Bioorganic & Medicinal …, 2024 - Elsevier
Compared to small molecules and antibodies, cyclic peptides exhibit unique biochemical
and therapeutic attributes in the realm of pharmaceutical applications. The interaction …

[HTML][HTML] Development of small molecule drugs targeting immune checkpoints

L Chen, X Zhao, X Liu, Y Ouyang, C Xu… - Cancer Biology & …, 2024 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are used to relieve and refuel anti-tumor immunity by
blocking the interaction, transcription, and translation of co-inhibitory immune checkpoints or …

Inhibitors of Immune Checkpoints: Small Molecule-and Peptide-Based Approaches

N Fuchs, L Zhang, L Calvo-Barreiro… - Journal of Personalized …, 2024 - mdpi.com
The revolutionary progress in cancer immunotherapy, particularly the advent of immune
checkpoint inhibitors, marks a significant milestone in the fight against malignancies …

From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3

N Fuchs, L Calvo-Barreiro, V Talagayev, S Pach… - bioRxiv, 2024 - biorxiv.org
Herein, we performed a virtual screening study to discover new scaffolds for small molecule-
based ligands of the immune checkpoint lymphocyte-activation gene 3 (LAG-3). Molecular …